ML25101A290

From kanterella
Revision as of 20:11, 15 April 2025 by StriderTol (talk | contribs) (StriderTol Bot insert)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
SRM-M250408B: Meeting with the Advisory Committee on the Medical Uses of Isotopes
ML25101A290
Person / Time
Issue date: 04/11/2025
From: Carrie Safford
NRC/SECY
To:
References
M250408B SRM-M250408B
Download: ML25101A290 (1)


Text

UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 April 11, 2025 IN RESPONSE, PLEASE REFER TO: M250408B MEMORANDUM TO:

Mirela Gavrilas, PhD Executive Director for Operations FROM:

Tomas E. Herrera, Acting Secretary

SUBJECT:

STAFF REQUIREMENTS - MEETING WITH THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES On April 8, 2025, the Commission was briefed on a variety of medical-related topics of regulatory interest by the following members of the Advisory Committee on the Medical Uses of Isotopes (ACMUI): Dr. Hossein Jadvar, ACMUI Chair and Nuclear Medicine Physician; Richard Green, ACMUI Nuclear Pharmacist; and Dr. Michael Folkert, ACMUI Radiation Oncologist. A statement from Josh Mailman, ACMUI Patients Rights Advocate, was read into the record. The topics discussed included an overview of ACMUI activities, growth in radiopharmaceutical therapy, ACMUIs review of training and experience for emerging medical technologies, and patients rights advocates perspectives on growth in medical uses of byproduct material.

The meeting, which was held in the Commissioners Hearing Room, One White Flint North, Rockville, Maryland at 10:00 a.m. Eastern Time, was open to members of the public attending in person and via webcast.

The Commission identified no requirements for staff action.

cc: Chairman Wright Commissioner Caputo Commissioner Hanson Commissioner Crowell Commissioner Marzano OGC CFO OCA OIG OPA ODs, RAs, ACRS, ASLBP PDR TOMAS HERRERA Digitally signed by TOMAS HERRERA Date: 2025.04.11 16:02:01 -04'00'